Series A · Biotech
RQ Bio: Series A
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
Funding history
Series A · This round$115M
Loading rounds…
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients